| Attribute |
Value |
| 52 Week Change |
-0.31214285 |
| Address1 |
Darwinweg 24 |
| All Time High |
21.99 |
| All Time Low |
6.1 |
| Ask |
12.17 |
| Ask Size |
1 |
| Average Analyst Rating |
1.0 - Strong Buy |
| Average Daily Volume10 Day |
8,950 |
| Average Daily Volume3 Month |
23,045 |
| Average Volume |
23,045 |
| Average Volume10Days |
8,950 |
| Beta |
0.074 |
| Bid |
17.34 |
| Bid Size |
1 |
| Book Value |
3.82 |
| City |
Leiden |
| Compensation As Of Epoch Date |
1,640,908,800 |
| Country |
Netherlands |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
9.36 |
| Current Ratio |
3.01 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
9.515 |
| Day Low |
9.31 |
| Debt To Equity |
41.885 |
| Display Name |
Pharming |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,746,703,800 |
| Earnings Call Timestamp Start |
1,746,703,800 |
| Earnings Growth |
-0.629 |
| Earnings Quarterly Growth |
-0.651 |
| Earnings Timestamp End |
1,753,938,000 |
| Earnings Timestamp Start |
1,753,938,000 |
| Ebitda |
32,879,000 |
| Ebitda Margins |
0.08972 |
| Enterprise To Ebitda |
19.362 |
| Enterprise To Revenue |
1.737 |
| Enterprise Value |
636,607,360 |
| Eps Current Year |
0.46 |
| Eps Forward |
0.0655 |
| Eps Trailing Twelve Months |
0.13 |
| Esg Populated |
0 |
| Exchange |
NGM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
10.8803 |
| Fifty Day Average Change |
-1.5202999 |
| Fifty Day Average Change Percent |
-0.1397296 |
| Fifty Two Week Change Percent |
-31.214285 |
| Fifty Two Week High |
21.34 |
| Fifty Two Week High Change |
-11.9800005 |
| Fifty Two Week High Change Percent |
-0.56138706 |
| Fifty Two Week Low |
9.31 |
| Fifty Two Week Low Change |
0.049999237 |
| Fifty Two Week Low Change Percent |
0.005370487 |
| Fifty Two Week Range |
9.31 - 21.34 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,608,733,800,000 |
| Float Shares |
69,656,999 |
| Forward Eps |
0.0655 |
| Forward P E |
142.90076 |
| Free Cashflow |
37,686,124 |
| Full Exchange Name |
NasdaqGM |
| Full Time Employees |
407 |
| Fullday Change |
-0.17000008 |
| Fullday Change Percent |
-1.7726806 |
| Fullday Price |
9.36 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.86522 |
| Gross Profits |
317,084,992 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0 |
| Held Percent Institutions |
0.0013400001 |
| Implied Shares Outstanding |
70,778,124 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,020-12-22 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands. |
| Long Name |
Pharming Group N.V. |
| Market |
us_market |
| Market Cap |
662,483,264 |
| Market State |
POST |
| Max Age |
86,400 |
| Message Board Id |
finmb_32943 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
9,301,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
782,521,629 |
| Number Of Analyst Opinions |
4 |
| Open |
9.5 |
| Operating Cashflow |
35,027,000 |
| Operating Margins |
0.01455 |
| Payout Ratio |
0.0 |
| Phone |
31 71 524 7400 |
| Previous Close |
9.59 |
| Price Eps Current Year |
20.347824 |
| Price Hint |
2 |
| Price To Book |
2.4502618 |
| Price To Sales Trailing12 Months |
1.8076977 |
| Profit Margins |
0.02538 |
| Quick Ratio |
2.309 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.0 |
| Region |
US |
| Regular Market Change |
-0.2300005 |
| Regular Market Change Percent |
-2.3983366 |
| Regular Market Day High |
9.515 |
| Regular Market Day Low |
9.31 |
| Regular Market Day Range |
9.31 - 9.515 |
| Regular Market Open |
9.5 |
| Regular Market Previous Close |
9.59 |
| Regular Market Price |
9.36 |
| Regular Market Time |
1,792,180,800 |
| Regular Market Volume |
8,923 |
| Return On Assets |
0.03466 |
| Return On Equity |
0.03647 |
| Revenue Growth |
-0.032 |
| Revenue Per Share |
5.22 |
| Sand P52 Week Change |
0.16207206 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
70,778,124 |
| Shares Percent Shares Out |
0.00029999999 |
| Shares Short |
20,097 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
25,053 |
| Short Name |
Pharming Group N.V. |
| Short Percent Of Float |
0.00029999999 |
| Short Ratio |
0.57 |
| Source Interval |
15 |
| Symbol |
PHAR |
| Target High Price |
39.0 |
| Target Low Price |
23.4 |
| Target Mean Price |
34.35 |
| Target Median Price |
37.5 |
| Total Cash |
158,280,992 |
| Total Cash Per Share |
2.236 |
| Total Debt |
113,295,000 |
| Total Revenue |
366,479,008 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
0.13 |
| Trailing P E |
72.0 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
14.153465 |
| Two Hundred Day Average Change |
-4.7934656 |
| Two Hundred Day Average Change Percent |
-0.33867788 |
| Type Disp |
Equity |
| Volume |
8,923 |
| Website |
https://www.pharming.com |
| Zip |
2,333 CR |